Stock Events

Stock Events

Solana 

M$33.6
0
+M$0+0% Friday 16:56

Statistics

Day High
33.6
Day Low
33.6
52W High
61
52W Low
33.6
Volume
2,022
Avg. Volume
55
Mkt Cap
5.04B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2025
Next
-926.18
-620.77
-315.36
-9.95
Expected EPS
-9.948400000000001
Actual EPS
N/A

Financials

-2,285.52%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
20.59MRevenue
-470.65MNet Income

Analyst Ratings

$54.40Average Price Target
The highest estimate is 54.40.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HSDT.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
LivaNova
LIVN
Mkt Cap3.49B
LivaNova operates in the neuromodulation space, providing therapies for neurological disorders, which puts them in direct competition with Helius Medical Technologies.
Novartis
NVS
Mkt Cap297.32B
Novartis is a large pharmaceutical company with a broad portfolio that includes treatments for neurological conditions, competing on a larger scale with Helius's niche market.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie has a strong presence in neuroscience, including R&D in neuromodulation, making it a competitor by offering alternative treatments for similar conditions.
Medtronic
MDT
Mkt Cap111.22B
Medtronic offers a wide range of neuromodulation devices, directly competing with Helius in providing medical technologies for neurological disorders.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol Myers Squibb, with its extensive portfolio in neuroscience, competes in developing treatments for conditions that Helius also aims to address with its technology.

About

Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
Show more...
CEO
ISIN
US42328V8761

Listings

MX
MX
HSDT.MX
F
DE
26H1.F
XNAS
US
HSDT
BOATS
BOATS
HSDT.BOATS

0 Comments

Share your thoughts

FAQ

What is Solana stock price today?▼
The current price of HSDT.MX is M$33.6 MXN — it has increased by +0% in the past 24 hours. Watch Solana stock price performance more closely on the chart.
What is Solana stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Solana stocks are traded under the ticker HSDT.MX.
What is Solana market cap?▼
Today Solana has the market capitalization of 5.04B
When is the next Solana earnings date?▼
Solana is going to release the next earnings report on May 07, 2026.
What were Solana earnings last quarter?▼
HSDT.MX earnings for the last quarter are -603.21 MXN per share, whereas the estimation was -926.18 MXN resulting in a +34.87% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is Solana revenue for the last year?▼
Solana revenue for the last year amounts to 20.59M MXN.
What is Solana net income for the last year?▼
HSDT.MX net income for the last year is -470.65M MXN.
When did Solana complete a stock split?▼
Solana has not had any recent stock splits.